Drug manufacturers are a step closer toward winning the liability protections they say they need before investing in medicines to combat a bird flu pandemic. Consumers seeking damages on claims they were harmed by a vaccine would have to prove willful misconduct by drug makers, instead of the lower standard of negligence used in many product liability cases. Opponents describe the protections, approved Monday by the House, as a "massive Christmas bonus to the drug companies."
December 20, 2005 at 12:00 AM
1 minute read
The original version of this story was published on Law.Com
Presented by BigVoodoo
This conference aims to help insurers and litigators better manage complex claims and litigation.
Recognizing innovation in the legal technology sector for working on precedent-setting, game-changing projects and initiatives.
Legalweek New York explores Business and Regulatory Trends, Technology and Talent drivers impacting law firms.
Search for the President and Dean California Western School of Law San Diego, California California Western School of Law (California ...
Duane Morris LLP has an opening for an associate with 2-3 years of experience with strong capital markets and corporate transactional backgr...
Our client, an established provider of professional liability insurance, has engaged us to identify a highly-qualified Senior Bad Faith Tria...
